207 related articles for article (PubMed ID: 6646877)
1. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
Kaplan SL; Berry PL; Mason EO; Kramer WG
Pediatr Pharmacol (New York); 1983; 3(1):29-36. PubMed ID: 6646877
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of moxalactam in adults].
Humbert G; Leroy A; Fillastre JP
Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
[TBL] [Abstract][Full Text] [Related]
3. The effect of hemodialysis on piperacillin pharmacokinetics.
Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
5. Effect of hemodialysis on ceftazidime pharmacokinetics.
Nikolaidis P; Tourkantonis A
Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].
Pioger JC; Taburet AM; Colin JN; Colaneri S; Fillastre JP; Singlas E
Therapie; 1989; 44(6):401-4. PubMed ID: 2623653
[TBL] [Abstract][Full Text] [Related]
7. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
8. Moxalactam pharmacokinetics during hemodialysis.
Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
Srinivasan S; Neu HC
Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
11. Moxalactam kinetics in hemodialysis.
Jacobson EJ; Zahrowski JJ; Nissenson AR
Clin Pharmacol Ther; 1981 Oct; 30(4):487-90. PubMed ID: 6456860
[TBL] [Abstract][Full Text] [Related]
12. Disposition of gabapentin in anuric subjects on hemodialysis.
Wong MO; Eldon MA; Keane WF; Türck D; Bockbrader HN; Underwood BA; Sedman AJ; Halstenson CE
J Clin Pharmacol; 1995 Jun; 35(6):622-6. PubMed ID: 7665723
[TBL] [Abstract][Full Text] [Related]
13. Hemodialyzability of sertraline.
Schwenk MH; Verga MA; Wagner JD
Clin Nephrol; 1995 Aug; 44(2):121-4. PubMed ID: 8529300
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
[TBL] [Abstract][Full Text] [Related]
15. Changes in erythromycin pharmacokinetics induced by renal failure.
Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
17. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis.
Goldstein SL; Murry DJ; May S; Aleksic A; Sowinski KM; Blaney S
Pediatr Nephrol; 2001 Dec; 16(12):1015-8. PubMed ID: 11793091
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of deflazacort in renal transplanted and hemodialyzed children.
Ferraris J; Krmar R; Flores D; Giogieri S; Díaz L; Tessler J
Clin Nephrol; 1998 Sep; 50(3):172-7. PubMed ID: 9776421
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
20. Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.
Aronoff GR; Brier ME; Nierste DM; Sloan RS
J Infect Dis; 1984 Jan; 149(1):9-15. PubMed ID: 6693791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
